Typing of Pseudomonas aeruginosa from hospitalized patients: A comparison of susceptibility and biochemical profiles with genotype

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 1, 2004, Pages 77-82

  Freitas, A L ^a,b,d   Barth, A L ^a,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d NONE   (Brazil)

Author keywords

Genotyping; Phenotypic markers; Pseudomonas aeruginosa; Typing

Indexed keywords

AMIKACIN; AZTREONAM; CARBENICILLIN; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; TIMENTIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOTYPE; BRAZIL; CHEMICAL ANALYSIS; CLONAL VARIATION; CONTROLLED STUDY; GENOTYPE; GRAM NEGATIVE INFECTION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESTRICTION MAPPING;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 1242284675     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004000100011     Document Type: Article

References (26)

1. Corona ALN, Miranda MGN, Leanos BM, Portilo LG, Hernadez AC, Anthor JR & Aguilar SB (2001). Epidemiologic study of Pseudomonas aeruginosa in critical patients and reservoirs. Archives of Medical Research, 32: 238-242.
2. Struelens MJ, Schwan V, Deplano A & Baran D (1993). Genome macro restriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients. Journal of Clinical Microbiology, 31: 2320-2326.
3. Grundmann H, Schneider C, Hartung D, Daschner F & Pitt TL (1995). Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. Journal of Clinical Microbiology, 33: 528-534.
4. Speijer H, Savelkoul PH, Bonten MJ, Stobberingh EE & Tjhie HT (1999). Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. Journal of Clinical Microbiology, 37: 3654-3661.
5. Williams T (1997). Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross-infection at cystic fibrosis clinics. British Journal of Biomedical Science, 54: 181-185.
6. Rodriguez B, Vasquez E, Sussmann O, Mattar S & Jaramillo CA (2000). Antimicrobial susceptibility and serotyping of Pseudomonas aeruginosa strains isolated in Bogota, Colombia. European Journal of Clinical Microbiology and Infectious Diseases, 19: 152-154.
7. Bergmans D, Bonten M, van Tiel F, Gaillard C, London N, van der Geest S, Leeuw P & Stobberingh E (1997). Value of phenotyping methods as an initial screening of Pseudomonas aeruginosa in epidemiologic studies. Infection, 25: 350-354.
8. Traub WH, Scheidhauer R, Leonhard B & Bauer D (1998). Surveillance of Pseudomonas aeruginosa in intensive care units: clusters of nosocomial cross-infection and encounter of a multiple-antibiotic resistant strain. Chemotherapy, 44: 243-259.
9. Muller MP & Gubina M (2000). Serotype, antimicrobial susceptibility and clone distribution of Pseudomonas aeruginosa in a university hospital. Zentralblatt für Bakteriologie, 289: 857-867.
10. Mifsud AJ, Watine J, Picard B, Charet JC, Solignac CB & Pitt TL (1997), Epidemiologically related and unrelated strains of Pseudomonas aeruginosa serotype O12 cannot be distinguished by phenotypic and genotypic typing. Journal of Hospital Infection, 36: 105-116.
11. Giacca M & Monti CB (1987). Multivariate analysis of antibiograms for typing Pseudomonas aeruginosa. European Journal of Clinical Microbiology, 6: 552-558.
12. Kiska DL & Gilligan PH (1999). Pseudomonas and Bulkholderia. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC & Yolken RH (Editors , Manual of Clinical Microbiology. 7th edn. American Society for Microbiology, Washington, DC, USA.
13. Cowan ST (1974). Manual for the Identification of Medical Bacteria. 2nd edn. Cambridge University Press, London, UK.
14. Pitt TL (1988). Epidemiological typing of Pseudomonas aeruginosa. European Journal of Clinical Microbiology and Infectious Diseases, 7: 238-247.
15. NCCLS - National Committee for Clinical Laboratory Standards (1999). Performance Standards for Antimicrobial Disk Susceptibility Tests. Wayne, PA, USA.
16. Kaufmann ME (1998). Pulsed-field gel electrophoresis. In: Woddford N & Johnson AP (Editors), Molecular Bacteriology. Protocols and Clinical Applications. Humana Press Inc., Totowa, NJ, USA, 33-50.
17. Tenover F, Arbeit R, Goering R, Mickelsen P, Murray B, Persing D & Swaminathan B (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology, 33: 2233-2239.
18. Hunter PR & Gaston MM (1989). Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. Journal of Clinical Microbiology, 26: 2465-2466.
19. Renders N, van Belkun A, Barth A, Goessens W, Mouton J & Verbrugh H (1996). Typing Pseudomonas aeruginosa strains from patients with cystic fibrosis: phenotyping versus genotyping. Clinical Microbiology and Infection, 1: 261-265.
20. Kinoshita M, Sawabe E & Okamura N (1997). Concept of segmentation in nosocomial epidemiology: epidemiological relation among antimicrobial-resistant isolates of Pseudomonas aeruginosa. Journal of Infection, 35: 269-276.
21. Silbert S, Barth AL & Sader HS (2001). Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients. Journal of Clinical Microbiology, 39: 3976-3981.
22. Bennett JV & Brachman PS (1992). Hospital Infections. 3rd edn. Little Brown and Company, Boston, MA, USA.
23. Verweij PE, Bijl D, Melchers WJ, Pauw BE, Meis JF, Hoogkamp JA & Voss A (1997). Pseudo-outbreak of multiresistant Pseudomonas aeruginosa in a hematology unit. Infection Control and Hospital Epidemiology, 18: 128-131.
24. Slama KB, Boudabous A, Skande G, Cherif A, Chedlya F, Boelenst H, Maaskant J, Verbrugh H & Belkum A (2001). Heterogeneity among infecting strains of P. aeruginosa in diverse departments of a large Tunisian hospital. Journal of Hospital Infection, 47: 325-327.
25. Griffith SJ, Nathan C, Selander RK, Chamberlin W, Gordon S, Kabins S & Weinstein R (1989). The epidemiology of Pseudomonas aeruginosa in oncology patients in a general hospital. Journal of Infectious Diseases, 160: 1030-1036.
26. Sader HS, Pignatari AC, Leme IL, Burattini MN, Tancresi R, Hollis RJ & Jones RN (1993). Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit. Diagnostic Microbiology and Infectious Disease, 17: 13-18.